TMDX - TransMedics: NOP Logistics And Transport Are Key Growth Drivers But Stock Is Pricey

2024-06-17 04:35:24 ET

Summary

• TransMedics Group is addressing the organ shortage crisis with their innovative Organ Care System.
• OCS adoption and National Organ Care System Program are driving impressive revenue growth for TransMedics.
• Despite overvaluation, TransMedics is a long-term winner with significant market opportunity and competitive position, making it a 'hold'.

Introduction

For decades, the number of viable organs available for donation has been unable to meet the number of patients in need of organ transplants. As a result, transplant waitlists have grown longer, extending wait times for patients in need of organs, and more patients dying each year waiting for viable matches. Depending on the organ, patients can experience average wait times ranging from 4 months for vital organs a heart or lungs to a staggering 5 years for kidneys, resulting in an average of 17 deaths every day while patients await an organ transplant....

For further details see: